Heme oxygenase -1 gene therapy: recent advances and therapeutic applications.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMID 17430129)

Published in Curr Gene Ther on April 01, 2007

Authors

Nader G Abraham1, Amit Asija, George Drummond, Stephen Peterson

Author Affiliations

1: Department of Pharmacology, New York Medical College, Valhalla, NY 10595, USA. nader_abraham@nymc.edu

Articles citing this

Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy. Am J Respir Cell Mol Biol (2009) 1.94

Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis. Gastroenterology (2008) 1.86

Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol (2012) 1.49

Carbon monoxide reverses diabetic gastroparesis in NOD mice. Am J Physiol Gastrointest Liver Physiol (2010) 1.11

Bench-to-bedside review: Carbon monoxide--from mitochondrial poisoning to therapeutic use. Crit Care (2009) 1.08

Age and sex dependent changes in liver gene expression during the life cycle of the rat. BMC Genomics (2010) 1.05

Targeting heme oxygenase-1 in vascular disease. Curr Drug Targets (2010) 1.05

Reactive oxygen species and dopamine receptor function in essential hypertension. Clin Exp Hypertens (2009) 1.02

N-butanol Extract from Melilotus Suaveolens Ledeb Affects Pro- and Anti-Inflammatory Cytokines and Mediators. Evid Based Complement Alternat Med (2007) 0.99

Inner anti-inflammatory mechanisms of petroleum ether extract from Melilotus suaveolens Ledeb. Inflammation (2007) 0.99

Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling. Br J Cancer (2013) 0.99

Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifies gene markers candidates. Toxicol Sci (2008) 0.96

Reactive oxygen species are not required for an arsenic trioxide-induced antioxidant response or apoptosis. J Biol Chem (2009) 0.95

Therapeutic potential of heme oxygenase-1/carbon monoxide in lung disease. Int J Hypertens (2012) 0.95

Heme cytotoxicity and the pathogenesis of immune-mediated inflammatory diseases. Front Pharmacol (2012) 0.94

Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation. Transl Res (2015) 0.90

Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study. Diabetes (2014) 0.89

Toxicogenomics and metabolomics of pentamethylchromanol (PMCol)-induced hepatotoxicity. Toxicol Sci (2011) 0.84

Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences. Basic Res Cardiol (2011) 0.84

Prevention of vancomycin induced nephrotoxicity: a review of preclinical data. Eur J Clin Pharmacol (2012) 0.81

Do Biliary Salts Have Role on Acute Kidney Injury Development? J Clin Med Res (2015) 0.80

Ethyl Acetate Extract of Artemisia anomala S. Moore Displays Potent Anti-Inflammatory Effect. Evid Based Complement Alternat Med (2014) 0.80

Bile pigments in pulmonary and vascular disease. Front Pharmacol (2012) 0.79

Dual protective role of HO-1 in transplanted liver grafts: a review of experimental and clinical studies. World J Gastroenterol (2011) 0.79

Loss of menin mediated by endothelial cells treated with CoPP is associated with increased maturation of adipocytes. Adipocyte (2013) 0.78

Gene expression profiles linked to AT1 angiotensin receptors in the kidney. Physiol Genomics (2010) 0.77

Change in the Interstitial Cells of Cajal and nNOS Positive Neuronal Cells with Aging in the Stomach of F344 Rats. PLoS One (2017) 0.75

eIF2α phosphorylation is required to prevent hepatocyte death and liver fibrosis in mice challenged with a high fructose diet. Nutr Metab (Lond) (2017) 0.75

Articles by these authors

L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice. J Lipid Res (2008) 1.80

D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation (2005) 1.78

Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. J Clin Microbiol (2009) 1.67

Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats. Hypertension (2009) 1.61

Sleep disorders and their association with laboratory pain sensitivity in temporomandibular joint disorder. Sleep (2009) 1.38

Multilocus sequence identification of Penicillium species in cork bark during plank preparation for the manufacture of stoppers. Res Microbiol (2008) 1.36

Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ Res (2003) 1.25

Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage, reversed by increases in pAMPK, heme oxygenase-1, and adiponectin. Stem Cells (2009) 1.14

Streamlining HIV testing in the emergency department-leveraging kiosks to provide true universal screening: a usability study. Telemed J E Health (2013) 1.13

CD163-Mediated hemoglobin-heme uptake activates macrophage HO-1, providing an antiinflammatory function. Circ Res (2006) 1.12

Heme oxygenase: the key to renal function regulation. Am J Physiol Renal Physiol (2009) 1.12

Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. Am J Physiol Heart Circ Physiol (2004) 1.09

Physiological significance of heme oxygenase in hypertension. Int J Biochem Cell Biol (2008) 1.04

Comparative analysis of two broad-range PCR assays for pathogen detection in positive-blood-culture bottles: PCR-high-resolution melting analysis versus PCR-mass spectrometry. J Clin Microbiol (2012) 1.01

Interdiction of the diabetic state in NOD mice by sustained induction of heme oxygenase: possible role of carbon monoxide and bilirubin. Antioxid Redox Signal (2007) 0.99

Bone marrow stem cell transplant into intra-bone cavity prevents type 2 diabetes: role of heme oxygenase-adiponectin. J Autoimmun (2008) 0.96

Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice. Cell Cycle (2007) 0.96

Improved myocardial perfusion in chronic diabetic mice by the up-regulation of pLKB1 and AMPK signaling. J Cell Biochem (2010) 0.92

Patients Can Accurately Perform Their Own Rapid HIV Point-of-Care Test in the Emergency Department. Point Care (2012) 0.89

Genetic suppression of HO-1 exacerbates renal damage: reversed by an increase in the antiapoptotic signaling pathway. Am J Physiol Renal Physiol (2006) 0.88

Proton dose perturbations caused by high-voltage leads from implanted cardioverter defibrillators. J Appl Clin Med Phys (2012) 0.86

Reverse transcription-PCR-electrospray ionization mass spectrometry for rapid detection of biothreat and common respiratory pathogens. J Clin Microbiol (2013) 0.85

Heme oxygenase-derived carbon monoxide restores vascular function in type 1 diabetes. Drug Metab Lett (2008) 0.83

Upregulation of heme oxygenase-1 combined with increased adiponectin lowers blood pressure in diabetic spontaneously hypertensive rats through a reduction in endothelial cell dysfunction, apoptosis and oxidative stress. Int J Mol Sci (2008) 0.82

Effect of hemin and carbon monoxide releasing molecule (CORM-3) on cGMP in rat penile tissue. J Sex Med (2007) 0.76

For "measurements of the dosimetric constants for a new 103Pd brachytherapy source," Brachytherapy 1 (2002) 110-119, by Stephen W. Peterson and Bruce Thomadsen. Brachytherapy (2008) 0.75

Trial of Time: Review of Frailty and Cardiovascular Disease. Cardiol Rev (2017) 0.75

Umeclidinium for treating COPD: an evaluation of pharmacologic properties, safety and clinical use. Expert Opin Drug Saf (2014) 0.75

Acquired thrombotic thrombocytopenic purpura associated with reversible severe renal failure requiring hemodialysis. Am J Ther (2012) 0.75

Major adverse cardiac events at follow-up after bare-metal stenting versus drug-eluting stenting in ST-elevated myocardial infarction. Am J Cardiol (2009) 0.75